Annual Cash & Cash Equivalents
$41.79 M
-$6.08 M-12.70%
December 31, 2023
Summary
- As of February 7, 2025, GLYC annual cash & cash equivalents is $41.79 million, with the most recent change of -$6.08 million (-12.70%) on December 31, 2023.
- During the last 3 years, GLYC annual cash & cash equivalents has fallen by -$95.24 million (-69.50%).
- GLYC annual cash & cash equivalents is now -80.09% below its all-time high of $209.92 million, reached on December 31, 2018.
Performance
GLYC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$14.39 M
-$7.99 M-35.71%
September 30, 2024
Summary
- As of February 7, 2025, GLYC quarterly cash and cash equivalents is $14.39 million, with the most recent change of -$7.99 million (-35.71%) on September 30, 2024.
- Over the past year, GLYC quarterly cash and cash equivalents has dropped by -$27.40 million (-65.56%).
- GLYC quarterly cash and cash equivalents is now -94.07% below its all-time high of $242.63 million, reached on March 31, 2018.
Performance
GLYC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GLYC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.7% | -65.6% |
| 3 y3 years | -69.5% | -84.0% |
| 5 y5 years | -80.1% | -84.0% |
GLYC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.7% | at low | -84.0% | at low |
| 5 y | 5-year | -73.6% | at low | -90.9% | at low |
| alltime | all time | -80.1% | +1708.7% | -94.1% | +522.9% |
GlycoMimetics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $14.39 M(-35.7%) |
| Jun 2024 | - | $22.39 M(-28.4%) |
| Mar 2024 | - | $31.28 M(-25.2%) |
| Dec 2023 | $41.79 M(-12.7%) | $41.79 M(-15.4%) |
| Sep 2023 | - | $49.41 M(-14.9%) |
| Jun 2023 | - | $58.04 M(-10.7%) |
| Mar 2023 | - | $65.00 M(+35.8%) |
| Dec 2022 | $47.87 M(-47.0%) | $47.87 M(-7.3%) |
| Sep 2022 | - | $51.62 M(-14.3%) |
| Jun 2022 | - | $60.24 M(-21.3%) |
| Mar 2022 | - | $76.52 M(-15.2%) |
| Dec 2021 | $90.25 M(-34.1%) | $90.25 M(-11.4%) |
| Sep 2021 | - | $101.92 M(-14.2%) |
| Jun 2021 | - | $118.85 M(-10.3%) |
| Mar 2021 | - | $132.47 M(-3.3%) |
| Dec 2020 | $137.03 M(-13.4%) | $137.03 M(-4.1%) |
| Sep 2020 | - | $142.87 M(-4.7%) |
| Jun 2020 | - | $149.84 M(-3.2%) |
| Mar 2020 | - | $154.82 M(-2.1%) |
| Dec 2019 | $158.20 M(-24.6%) | $158.20 M(-7.4%) |
| Sep 2019 | - | $170.89 M(-7.2%) |
| Jun 2019 | - | $184.17 M(-5.8%) |
| Mar 2019 | - | $195.56 M(-6.8%) |
| Dec 2018 | $209.92 M | $209.92 M(-4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $219.83 M(-4.2%) |
| Jun 2018 | - | $229.43 M(-5.4%) |
| Mar 2018 | - | $242.63 M(+95.8%) |
| Dec 2017 | $123.92 M(+209.5%) | $123.92 M(+9.8%) |
| Sep 2017 | - | $112.87 M(-5.3%) |
| Jun 2017 | - | $119.15 M(+244.5%) |
| Mar 2017 | - | $34.59 M(-13.6%) |
| Dec 2016 | $40.04 M(-14.4%) | $40.04 M(-11.6%) |
| Sep 2016 | - | $45.28 M(-14.7%) |
| Jun 2016 | - | $53.09 M(+36.7%) |
| Mar 2016 | - | $38.83 M(-17.0%) |
| Dec 2015 | $46.80 M(-15.2%) | $46.80 M(-12.9%) |
| Sep 2015 | - | $53.76 M(+33.6%) |
| Jun 2015 | - | $40.23 M(-13.6%) |
| Mar 2015 | - | $46.57 M(-15.6%) |
| Dec 2014 | $55.20 M(+2288.9%) | $55.20 M(-10.0%) |
| Sep 2014 | - | $61.36 M(-7.3%) |
| Jun 2014 | - | $66.22 M(+16.2%) |
| Mar 2014 | - | $56.97 M(+2365.4%) |
| Dec 2013 | $2.31 M(-86.7%) | $2.31 M(-70.0%) |
| Sep 2013 | - | $7.69 M(-28.7%) |
| Jun 2013 | - | $10.78 M(-38.0%) |
| Dec 2012 | $17.37 M(-38.3%) | $17.37 M |
| Dec 2011 | $28.17 M | - |
FAQ
- What is GlycoMimetics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for GlycoMimetics?
- What is GlycoMimetics annual cash & cash equivalents year-on-year change?
- What is GlycoMimetics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for GlycoMimetics?
- What is GlycoMimetics quarterly cash and cash equivalents year-on-year change?
What is GlycoMimetics annual cash & cash equivalents?
The current annual cash & cash equivalents of GLYC is $41.79 M
What is the all time high annual cash & cash equivalents for GlycoMimetics?
GlycoMimetics all-time high annual cash & cash equivalents is $209.92 M
What is GlycoMimetics annual cash & cash equivalents year-on-year change?
Over the past year, GLYC annual cash & cash equivalents has changed by -$6.08 M (-12.70%)
What is GlycoMimetics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GLYC is $14.39 M
What is the all time high quarterly cash and cash equivalents for GlycoMimetics?
GlycoMimetics all-time high quarterly cash and cash equivalents is $242.63 M
What is GlycoMimetics quarterly cash and cash equivalents year-on-year change?
Over the past year, GLYC quarterly cash and cash equivalents has changed by -$27.40 M (-65.56%)